Candidate gene polymorphisms and their association with hypertension in Malays

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 46-50

  Ghazali, Dzuzaini M ^a,b   Rehman, Asia ^c   Rahman, Abdul Rashid A ^d  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c SCHOOL OF HEALTH SCIENCES   (Malaysia)

^d CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Angiotensinogen gene; Endothelial nitric oxide synthase gene; Hypertension; Malays; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; ASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ANGIOTENSINOGEN; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 37249012924     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.002     Document Type: Article

References (24)

1. Staessen J.A., Kuznetsova T., Wang J.G., Emelianov D., Vlietinck R., and Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 17 (1999) 9-17
2. Lim T.O., and Morad Z. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singap Med J 45 (2004) 20-27
3. Oparil S., Zaman M.A., and Calhoun D.A. Pathogenesis of hypertension. Ann Intern Med 139 (2003) 761-776
4. Walker W.G., Whelton P.K., Saito H., Russell R.P., and Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1 (1979) 287-291
5. Fasola A.F., Martz B.L., and Helmer O.M. Renin activity during supine exercise in normotensives and hypertensives. J Appl Physiol 21 (1966) 1709-1712
6. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
7. Vallance P., Collier J., and Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2 (1989) 997-1000
8. Say Y.H., Ling K.H., Duraisamy G., Isaac S., and Rosli R. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study. BMC Cardiovasc Disord 5 (2005) 7
9. Guzik T.J., Black E., West N.E., et al. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J Med Genet 100 (2001) 130-137
10. Gaillard I., Clauser E., and Corvol P. Structure of human angiotensinogen gene. DNA 8 (1989) 87-99
11. Caulfield M., Lavender P., Farrall M., et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330 (1994) 1629-1633
12. Hingorani A.D., Sharma P., Jia H., Hopper R., and Brown M.J. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 28 (1996) 907-911
13. Hata A., Namikawa C., Sasaki M., et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93 (1994) 1285-1287
14. Nishiuma S., Kario K., Kayaba K., et al. Effect of the angiotensinogen gene Met235 → Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 13 (1995) 717-722
15. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 71 (1992) 169-180
16. Kishimoto T., Suyama A., Igarashi A., et al. Angiotensinogen gene variation and hypertension in a cohort study in Japanese. J Epidemiol 11 (2001) 115-119
17. Iwai N., Shimoike H., Ohmichi N., and Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 25 (1995) 688-693
18. Huang P.L., Huang Z., Mashimo H., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 (1995) 239-242
19. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
20. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66 (2000) 2557-2562
21. Kato N., Sugiyama T., Morita H., et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33 (1999) 933-936
22. Kishimoto T., Misawa Y., Kaetu A., et al. eNOS Glu298Asp polymorphism and hypertension in a cohort study in Japanese. Prev Med 39 (2004) 927-931
23. Zhao Q., Su S.Y., Chen S.F., Li B., and Gu D.F. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med J (Engl) 119 (2006) 1065-1071
24. Zhang L.P., Wang S.Z., Zhao X.X., et al. [Association between endothelial nitric oxide synthase gene (G894T) polymorphism and essential hypertension in Uygur populations]. Zhonghua Xin Xue Guan Bing Za Zhi 34 (2006) 403-406